NuCana (NCNA)
(Delayed Data from NSDQ)
$3.05 USD
-0.28 (-8.41%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $4.05 +1.00 (32.79%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
NCNA 3.05 -0.28(-8.41%)
Will NCNA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NCNA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NCNA
NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study
Bears are Losing Control Over NuCana PLC Sponsored ADR (NCNA), Here's Why It's a 'Buy' Now
NCNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
NuCana PLC Sponsored ADR (NCNA) Upgraded to Buy: What Does It Mean for the Stock?
Here's Why NuCana PLC Sponsored ADR (NCNA) is Poised for a Turnaround After Losing 26.5% in 4 Weeks
NuCana PLC Sponsored ADR (NCNA) Upgraded to Buy: What Does It Mean for the Stock?
Other News for NCNA
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Truist Financial Keeps Their Buy Rating on Nucana (NCNA)
Crude Oil Surges Over 1%; Instil Bio Shares Plunge